191 related articles for article (PubMed ID: 15345871)
21. Emergence of Japanese encephalitis among adults 40 years of age or older in northern China: Epidemiological and clinical characteristics.
Wu D; Chen X; Liu W; Fu S; Li F; Liang G; Yang G; Zheng H; Li J; Yin Z; Li Y; Wang H
Transbound Emerg Dis; 2021 Nov; 68(6):3415-3423. PubMed ID: 33283432
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of Japanese encephalitis (JE) immunization in Bali, Indonesia.
Liu W; Clemens JD; Kari K; Xu ZY
Vaccine; 2008 Aug; 26(35):4456-60. PubMed ID: 18602436
[TBL] [Abstract][Full Text] [Related]
23. Reduction patterns of Japanese encephalitis incidence following vaccine introduction into long-term expanded program on immunization in Yunnan Province, China.
Hu XT; Li QF; Ma C; Zhao ZX; He LF; Tang TT; Yu W; Owiti P
Infect Dis Poverty; 2019 Dec; 8(1):102. PubMed ID: 31818328
[TBL] [Abstract][Full Text] [Related]
24. Current recommendations for the Japanese encephalitis vaccine.
Chen HL; Chang JK; Tang RB
J Chin Med Assoc; 2015 May; 78(5):271-5. PubMed ID: 25841620
[TBL] [Abstract][Full Text] [Related]
25. [The progress and challenge of Japanese encephalitis control and prevention in China].
Wang HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):133-135. PubMed ID: 30744284
[TBL] [Abstract][Full Text] [Related]
26. Past, present, and future of Japanese encephalitis.
Erlanger TE; Weiss S; Keiser J; Utzinger J; Wiedenmayer K
Emerg Infect Dis; 2009 Jan; 15(1):1-7. PubMed ID: 19116041
[TBL] [Abstract][Full Text] [Related]
27. Product review on the JE vaccine IXIARO.
Firbas C; Jilma B
Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
[TBL] [Abstract][Full Text] [Related]
28. Japanese encephalitis: development of new candidate vaccines.
Bharati K; Vrati S
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
[TBL] [Abstract][Full Text] [Related]
29. A Bibliometric Analysis of Global Research on Japanese Encephalitis From 1934 to 2020.
Xu C; Zhang W; Pan Y; Wang G; Yin Q; Fu S; Li F; He Y; Xu S; Wang Z; Liang G; Nie K; Wang H
Front Cell Infect Microbiol; 2022; 12():833701. PubMed ID: 35155284
[TBL] [Abstract][Full Text] [Related]
30. Japanese Encephalitis Surveillance and Immunization - Asia and Western Pacific Regions, 2016.
Heffelfinger JD; Li X; Batmunkh N; Grabovac V; Diorditsa S; Liyanage JB; Pattamadilok S; Bahl S; Vannice KS; Hyde TB; Chu SY; Fox KK; Hills SL; Marfin AA
MMWR Morb Mortal Wkly Rep; 2017 Jun; 66(22):579-583. PubMed ID: 28594790
[TBL] [Abstract][Full Text] [Related]
31. Epidemiological situation of Japanese encephalitis in Nepal.
Bista MB; Shrestha JM
JNMA J Nepal Med Assoc; 2005; 44(158):51-6. PubMed ID: 16554872
[TBL] [Abstract][Full Text] [Related]
32. Estimates of the global burden of Japanese encephalitis and the impact of vaccination from 2000-2015.
Quan TM; Thao TTN; Duy NM; Nhat TM; Clapham H
Elife; 2020 May; 9():. PubMed ID: 32450946
[TBL] [Abstract][Full Text] [Related]
33. Effect of different vaccine strategies for the control of Japanese encephalitis in mainland China from 1961 to 2020: A quantitative analysis.
Shi T; Meng L; Li D; Jin N; Zhao X; Zhang X; Liu Y; Zheng H; Zhao X; Li J; Shen X; Ren X
Vaccine; 2022 Oct; 40(43):6243-6254. PubMed ID: 36137902
[TBL] [Abstract][Full Text] [Related]
34. Perceptions among the U.S. population of value of Japanese encephalitis (JE) vaccination for travel to JE-endemic countries.
Hills SL; Fischer M; Biggerstaff BJ
Vaccine; 2020 Feb; 38(9):2117-2121. PubMed ID: 31992482
[TBL] [Abstract][Full Text] [Related]
35. Vaccine strategies for the control and prevention of Japanese encephalitis in Mainland China, 1951-2011.
Gao X; Li X; Li M; Fu S; Wang H; Lu Z; Cao Y; He Y; Zhu W; Zhang T; Gould EA; Liang G
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3015. PubMed ID: 25121596
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study.
Bista MB; Banerjee MK; Shin SH; Tandan JB; Kim MH; Sohn YM; Ohrr HC; Tang JL; Halstead SB
Lancet; 2001 Sep; 358(9284):791-5. PubMed ID: 11564484
[TBL] [Abstract][Full Text] [Related]
37. Japanese encephalitis for a reference to international travelers.
Oya A; Kurane I
J Travel Med; 2007; 14(4):259-68. PubMed ID: 17617849
[TBL] [Abstract][Full Text] [Related]
38. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
[TBL] [Abstract][Full Text] [Related]
39. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.
Tsai TF
Vaccine; 2000 May; 18 Suppl 2():1-25. PubMed ID: 10821969
[TBL] [Abstract][Full Text] [Related]
40. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
